This settlement is closed!
Please see what other class action settlements you might qualify to claim cash from in our Open Settlements directory!
AstraZeneca and Handa Pharmaceuticals agreed to pay a combined $5.475 million to resolve claims they violated antitrust laws by keeping Seroquel XR generic medications off the market.
The Seroquel XR antitrust settlement benefits entities that purchased, paid and/or reimbursed some or all of the purchase price of Seroquel XR or quetiapine fumarate ER 50 mg, 150 mg, 200 mg and/or 300 mg tablets in certain states between Sept. 5, 2015, and Dec. 9, 2024.
A full list of eligible states can be found in the “Who’s Eligible” section below.
According to the class action lawsuit, AstraZeneca and Handa violated state antitrust laws by taking actions to keep generic versions of Seroquel XR off the market. This allegedly harmed competition and caused third-party payers to overpay for Seroquel XR and generic quetiapine fumarate ER.
Seroquel XR is an antipsychotic medication used to treat schizophrenia, bipolar disorder and depression. The generic version of Seroquel XR is quetiapine fumarate ER.
AstraZeneca and Handa have not admitted any wrongdoing but agreed to a $5.475 million settlement to resolve the antitrust class action lawsuit.
Under the terms of the settlement, class members can receive a cash payment based on the amount they paid for Seroquel XR or quetiapine fumarate ER between Sept. 5, 2015, and Dec. 9, 2024. No payment estimates are available at this time.
The deadline for exclusion and objection was Feb. 24, 2025.
The final approval hearing for the Seroquel XR antitrust settlement was scheduled for April 23, 2025.
To receive settlement benefits, class members must submit a valid claim form by June 9, 2025.
Who’s Eligible
The settlement benefits third-party payors who purchased, paid for or provided reimbursement for some or all of the purchase price of Seroquel XR or quetiapine fumarate ER 50 mg, 150 mg, 200 mg and/or 300 mg tablets between Sept. 5, 2015, and Dec. 9, 2024, in Arizona, Arkansas, California, the District of Columbia, Florida, Hawaii, Illinois, Iowa, Kansas, Maine, Maryland, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Oregon, Rhode Island, South Dakota, Tennessee, Vermont, West Virginia or Wisconsin.
Potential Award
Varies
Proof of Purchase
Class members must provide documentation of their purchases, payments and/or reimbursements for 50 mg, 150 mg, 200 mg and 300 mg strengths of Seroquel XR and generic quetiapine fumarate ER.
Claim Form
NOTE: If you do not qualify for this settlement do NOT file a claim.
Remember: you are submitting your claim under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim. If you’re unsure if you qualify, please read the FAQ section of the Settlement Administrator’s website to ensure you meet all standards (Top Class Actions is not a Settlement Administrator). If you don’t qualify for this settlement, check out our database of other open class action settlements you may be eligible for.
Claim Form Deadline
06/09/2025
Case Name
In re: Seroquel XR (Extended Release Quetiapine Fumarate) Antitrust Litigation, Case No. 1:20-cv-01076-CFC (D. Del.), in the U.S. District Court for the District of Delaware
Final Hearing
04/23/2025
Settlement Website
Claims Administrator
Claims Administrator
P.O. Box 5017
Portland, OR 97208-5017
[email protected]
888-884-8072
Class Counsel
Robert G. Eisler
GRANT & EISENHOFER P.A.
Defense Counsel
Benjamin M. Greenblum
WILLIAMS & CONNOLLY LLP
James E. Gallagher
DAVIS, MALM & D’AGOSTINE P.C.
Read About More Class Action Lawsuits & Class Action Settlements:
- $1.5M SeaWorld annual pass class action settlement
- Family Dollar ground coffee class action settlement
- $3.1M Midland States Bank overdraft fees class action settlement
- $6.75M Quaker Oats class action settlement
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2025 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
9 thoughts on$5.475M Seroquel XR class action settlement
Please add me
Add me
Add me
Please add me
Please add me
Please add me
Pls add me
Pls add me
Why can’t Louisiana residents file a claim